Viral hepatitis screening guideline before biological drug use in rheumatic patients

Biological drugs (tumor necrosis factor inhibitors, rituximab, tocilizumab, abatacept, and tofacitinib) are important treatment alternatives in rheumatology, particularly for resistant patients. However, they may cause hepatitis B virus (HBV) and hepatitis C virus (HCV) reactivation; for instance, H...

全面介紹

Na minha lista:
書目詳細資料
發表在:Eur J Rheumatol
Main Authors: Karadağ, Ömer, Kaşifoğlu, Timuçin, Özer, Birol, Kaymakoğlu, Sabahattin, Kuş, Yeşim, İnanç, Murat, Keser, Gökhan, Kiraz, Sedat
格式: Artigo
語言:Inglês
出版: Medical Research and Education Association 2016
主題:
Review
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5042270/
https://ncbi.nlm.nih.gov/pubmed/27708965
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/eurjrheum.2015.150072
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍